Unwrap.Fund
See how PRHSX fits your portfolio →
MF · holdings as filed 2026-03-31

What's inside PRHSX?

T. Rowe Price Health Sciences Fund, Inc.
Holdings
287
positions in the fund
Top 10
39%
of fund assets
Expense ratio
0.83%
net, per year
Fund size
$11B
total net assets
Top 15 holdings
1
LLYELI LILLY & CO
10.14%
2
TMOTHERMO FISHER SCIENTIFIC INC
4.07%
3
ISRGINTUITIVE SURGICAL INC
3.65%
4
SYKSTRYKER CORP
3.46%
5
MRKMERCK & CO. INC.
3.44%
6
AZNASTRAZENECA PLC
3.17%
7
UNHUNITEDHEALTH GROUP INC
3.09%
8
ARGXARGENX SE - ADR
2.92%
9
ABBVABBVIE INC
2.84%
10
REGNREGENERON PHARMACEUTICALS
2.65%
11
GILDGILEAD SCIENCES INC
2.60%
12
JNJJOHNSON & JOHNSON
2.44%
13
VRTXVERTEX PHARMACEUTICALS INC
2.42%
14
DHRDANAHER CORP
2.05%
15
ALNYALNYLAM PHARMACEUTICALS INC
1.62%
Sectors
1Health Care
84%
2Unclassified
8%
3Financials
5%
4Industrials
2%
5Consumer Discretionary
1%
Geography
1United States
86%
2Unclassified
6%
3United Kingdom
4%
4Switzerland
1%
5Bermuda
1%
6Germany
1%
7Japan
1%
8Cayman Islands
0%
Hold PRHSX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-03-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.